The vaccine developed by Sinopharm shows good immunity protection against the virus, says the Chinese company. SINGAPORE: The first Chinese mpox vaccine has been approved for clinical trials across China starting on Monday (Sep 9), with the company behind it saying that early studies show promising results and effective immunity protection against the highly infectious virus. The jab was developed by Shanghai Institute of Biological Products, a subsidiary of Chinese state-owned pharmaceutical